Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Etiology and pathogens of fungal endophthalmitis].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2015

Same author

Eucommia ulmoides Oliv. bark aqueous extract inhibits osteoarthritis in a rat model of osteoarthritis.

Journal of ethnopharmacology·2015

Same author

Aucubin prevents interleukin-1 beta induced inflammation and cartilage matrix degradation via inhibition of NF-κB signaling pathway in rat articular chondrocytes.

International immunopharmacology·2015

Same author

Treatment with recombinant lubricin attenuates osteoarthritis by positive feedback loop between articular cartilage and subchondral bone in ovariectomized rats.

Bone·2015

Same author

Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress.

Scientific reports·2015

Same author

Authors' reply.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2015

Search research articles

Related Experiment Videos

A Unified Differential Denoising Learning Framework With a Pre-Trained Model and Fuzzy Graph Networks for Drug-Drug

Zhuo Chen, Xiaofeng Man, Chao Sun

IEEE Transactions on Neural Networks and Learning Systems

|July 1, 2026

Summary

This study introduces UDPF-DDI, a novel framework for predicting drug-drug interactions (DDIs). It improves accuracy by effectively handling molecular data uncertainty and denoising features for safer medication use.

Related Experiment Videos

Area of Science:

Pharmacology
Computational Chemistry
Bioinformatics

Background:

Drug-drug interactions (DDIs) are a major concern in combination therapy, impacting medication safety.
Accurate DDI prediction is vital for drug development and clinical practice.
Existing prediction methods struggle with molecular data uncertainty and noise.

Purpose of the Study:

To develop a robust framework for predicting drug-drug interactions (DDIs).
To address limitations in current DDI prediction models concerning data uncertainty and feature noise.

Main Methods:

Proposed UDPF-DDI: a unified differential denoising learning framework.
Utilized Uni-Mol2 for high-dimensional features and RDKit for graph structures.
Employed a parallel three-channel encoder with fuzzy graph convolution neural networks (FGCNN) and a differential Transformer for denoising.

Main Results:

UDPF-DDI demonstrated significant performance improvements over state-of-the-art models on multiple datasets.
The framework excelled in managing data uncertainty and denoising drug features.
Achieved superior results across various evaluation metrics in cross-validation studies.

Conclusions:

UDPF-DDI offers a powerful and accurate approach for DDI prediction.
The framework enhances medication safety by improving the reliability of DDI predictions.
This method provides a valuable tool for drug development and clinical decision-making.